Evidence map›Paper›PMID 38498015›Full record

ArticleCannabis and cannabinoid research2024

Cannabis Dependence is Associated with Reduced Hippocampal Subregion Volumes Independently of Sex: Findings from an ENIGMA Addiction Working Group Multi-Country Study.

Valentina Lorenzetti, Alexandra Gaillard, Eugene McTavish, Sally Grace, Maria Gloria Rossetti, Albert Batalla, Marcella Bellani, Paolo Brambilla, Yann Chye, Patricia Conrod and 13 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Cannabis and cannabinoid research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 15 institutions in 6 countries.

Valentina LorenzettiNeuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Melbourne, Australia.ORCID 0000-0002-5917-7068
Alexandra GaillardNeuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Melbourne, Australia.
Eugene McTavishNeuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Melbourne, Australia.
Sally GraceNeuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Melbourne, Australia.
Maria Gloria RossettiUOC Psichiatria, Azienda Ospedaliera Universitaria Integrata (AOUI), Verona, Italy.
Albert BatallaDepartment of Psychiatry, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.
Marcella BellaniSection of Psychiatry, Department of Neuroscience, Biomedicine and Movement Science, University of Verona, Verona, Italy.
Paolo BrambillaUOC Psichiatria, Azienda Ospedaliera Universitaria Integrata (AOUI), Verona, Italy.
Yann ChyeTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Australia.
Patricia ConrodDepartment of Psychiatry, Université de Montreal, CHU Ste Justine Hospital, Montreal, Canada.
Janna CousijnNeuroscience of Addiction Lab, Center for Substance Use and Addiction Research (CESAR), Department of Psychology, Education & Child Studies, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Izelle LabuschagneNeuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Melbourne, Australia.
Adam ClementeNeuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Melbourne, Australia.
Scott MackeyDepartment of Psychiatry, University of Vermont, Burlington, Vermont, USA.
Peter RendellNeuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Melbourne, Australia.
Nadia SolowijSchool of Psychology, Faculty of the Arts, Social Sciences and Humanities, University of Wollongong, Wollongong, Australia.
Chao SuoTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Australia.
Chiang-Shan R LiDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Gill TerrettNeuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Melbourne, Australia.
Paul M ThompsonDepartment of Neurology, Imaging Genetics Center, Stevens Institute for Neuroimaging & Informatics, Keck School of Medicine, University of Southern California, Marina del Rey, California, USA.
Murat YücelQIMR Berghofer Medical Research Institute, Herston, Australia.
Hugh GaravanSchool of Psychology, Faculty of Health and Behavioural Sciences, University of Queensland, St Lucia, Australia.
Carl A RobertsDepartment of Psychology, Institute of Population Health, University of Liverpool, Liverpool, United Kingdom.
Australian Catholic University · AUThe University of Queensland · AUMonash University · AUUniversity of Verona · ITIVO Addiction Research Institute · NLQIMR Berghofer Medical Research Institute · AUSwinburne University of Technology · AUUniversité de Montréal · CAUniversity of Liverpool · GBUniversity of Milan · ITUniversity of Southern California · USUniversity of Vermont · USUniversity of Wollongong · AUUtrecht University · NLYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AmygdalaHippocampusMagnetic Resonance ImagingMarijuana AbuseAdultCase-Control StudiesFemaleHumansMaleMiddle AgedOrgan SizeSex CharacteristicsYoung AdultaddictioncannabisCB1dependencehippocampusMRIneuroimagingsex differencesTHC

Identifiers

PMID38498015
PMCPMC11685300
OpenAlexW4392908215

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.